Search research articles
Contact Us
Filters
Showing results (41-50 of 137) with videos related to
Page
of 14
Sort By:
Medical and Pediatric Oncology
|
November 5, 2003
Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience
Brian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
Nuclear Medicine Communications
|
December 6, 2024
Safety observations in neuroblastoma patients undergoing 18 F- m FBG PET
Neeta Pandit-Taskar, Ellen Basu, Eloisa Balquin, et al.
JCO Precision Oncology
|
August 10, 2023
Anaplastic Lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in Adults
Jessica Stiefel, Brian H Kushner, Stephen S Roberts, et al.
Journal of Pediatric Hematology/Oncology
|
June 1, 2017
Epigenetic Combination Therapy for Children With Secondary Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML) and Concurrent Solid Tumor Relapse
Chana L Glasser, Alice Lee, Don Eslin, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
January 7, 2022
F-18 meta-fluorobenzylguanidine PET imaging of myocardial sympathetic innervation
Milan Grkovski, Pat B Zanzonico, Shakeel Modak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2014
Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remission
Brian H Kushner, Irene Y Cheung, Shakeel Modak, et al.
Pediatric Blood & Cancer
|
March 19, 2011
Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastoma
Shakeel Modak, Irene Y Cheung, Brian H Kushner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2004
Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma
Brian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
Oncoimmunology
|
June 27, 2013
Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-<i>D</i>-glucan: A Phase I study in patients with chemoresistant neuroblastoma
Shakeel Modak, Brian H Kushner, Kim Kramer, et al.
Cancer
|
May 2, 2013
Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody
Brian H Kushner, Shakeel Modak, Ellen M Basu, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 137) with videos related to
Sort By:
Page
of 14
Medical and Pediatric Oncology
|
November 5, 2003
Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience
Brian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
Nuclear Medicine Communications
|
December 6, 2024
Safety observations in neuroblastoma patients undergoing 18 F- m FBG PET
Neeta Pandit-Taskar, Ellen Basu, Eloisa Balquin, et al.
JCO Precision Oncology
|
August 10, 2023
Anaplastic Lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in Adults
Jessica Stiefel, Brian H Kushner, Stephen S Roberts, et al.
Journal of Pediatric Hematology/Oncology
|
June 1, 2017
Epigenetic Combination Therapy for Children With Secondary Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML) and Concurrent Solid Tumor Relapse
Chana L Glasser, Alice Lee, Don Eslin, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
January 7, 2022
F-18 meta-fluorobenzylguanidine PET imaging of myocardial sympathetic innervation
Milan Grkovski, Pat B Zanzonico, Shakeel Modak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2014
Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remission
Brian H Kushner, Irene Y Cheung, Shakeel Modak, et al.
Pediatric Blood & Cancer
|
March 19, 2011
Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastoma
Shakeel Modak, Irene Y Cheung, Brian H Kushner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2004
Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma
Brian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
Oncoimmunology
|
June 27, 2013
Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-<i>D</i>-glucan: A Phase I study in patients with chemoresistant neuroblastoma
Shakeel Modak, Brian H Kushner, Kim Kramer, et al.
Cancer
|
May 2, 2013
Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody
Brian H Kushner, Shakeel Modak, Ellen M Basu, et al.
Page
of 14